TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 4 | -0 | 3 | -3 | -16 | -25 | -16 | -9 |
| S | %wins | 50 | 25 | 75 | 100 | 100 | 75 | 71 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/15/15 18:47 | 1/13/15 | ACOR | Acorda Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Kelley John P | NY | D | S.d | -440 | 44.00 | 25 | -10 | -100 | 0 | D | 55 | 41 | 42 | 38 | 18 | 12 | 6 | 2 | 3 | 5 | -12 | -15 | -14 | -5 | ||
12/22/14 16:15 | 12/18/14 | ACOR | Acorda Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Kelley John P | NY | D | S.d | -400 | 40.00 | 20 | -10 | -100 | 0 | D | 61 | 38 | 14 | 37 | 14 | 13 | 5 | 5 | -4 | 3 | 9 | -13 | -13 | 5 | ||
8/6/13 15:58 | 8/2/13 | ACOR | Acorda Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Kelley John P | NY | D | S.d | -570 | 38.00 | 12 | -15 | -100 | 0 | D | 38 | 61 | 28 | 7 | 15 | -3 | -3 | -3 | -1 | -3 | -2 | -16 | -22 | -20 | ||
1/5/07 17:08 | 1/3/07 | MDCO | Medicines Co /de | DE | Health | Drug | Pharmaceutical Preparations | Kelley John P | NJ | DO | P,COO | S.d | -1,595 | 31.91 | 33 | -50 | -100 | 0 | D | 13 | 89 | 68 | 42 | 18 | 3 | 1 | 1 | 1 | 6 | -8 | -19 | -49 | -42 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |